tradingkey.logo

Helix Acquisition Corp II

HLXB
9.900USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
232.74MMarket Cap
48.70P/E TTM

Helix Acquisition Corp II

9.900
0.0000.00%

More Details of Helix Acquisition Corp II Company

Helix Acquisition Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which it refers to as its initial business combination. The Company has not selected any specific business combination target and it has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination. While it may pursue a business combination target in any business or industry, it intends to focus on healthcare or healthcare related industries. The Company has not generated any revenue.

Helix Acquisition Corp II Info

Ticker SymbolHLXB
Company nameHelix Acquisition Corp II
IPO dateFeb 09, 2024
CEOMs. Bihua Chen
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 09
AddressC/O Cormorant Asset Management, Lp
CityBOSTON
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code02116
Phone18577020377
Website
Ticker SymbolHLXB
IPO dateFeb 09, 2024
CEOMs. Bihua Chen

Company Executives of Helix Acquisition Corp II

Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cormorant Asset Management, LP
22.35%
BridgeBio Pharma, Inc.
18.24%
Deerfield Management Company, L.P.
6.11%
BC Global Opportunities IX LP
5.46%
Omega Fund Management, LLC
4.11%
Other
43.73%
Shareholders
Shareholders
Proportion
Cormorant Asset Management, LP
22.35%
BridgeBio Pharma, Inc.
18.24%
Deerfield Management Company, L.P.
6.11%
BC Global Opportunities IX LP
5.46%
Omega Fund Management, LLC
4.11%
Other
43.73%
Shareholder Types
Shareholders
Proportion
Hedge Fund
41.69%
Corporation
26.98%
Investment Advisor/Hedge Fund
10.78%
Venture Capital
10.12%
Investment Advisor
5.37%
Research Firm
0.26%
Individual Investor
0.11%
Other
4.68%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
73
54.57M
68.22%
+15.19M
2025Q3
53
37.59M
47.47%
+19.96M
2025Q2
45
24.80M
131.18%
+8.09M
2025Q1
44
17.89M
94.60%
+829.91K
2024Q4
41
17.82M
94.24%
+1.30M
2024Q3
37
17.47M
92.41%
+1.09M
2024Q2
35
17.48M
94.85%
+1.41M
2024Q1
33
17.17M
90.80%
+8.90M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Cormorant Asset Management, LP
17.88M
22.35%
--
--
Sep 30, 2025
BridgeBio Pharma, Inc.
14.59M
18.24%
+784.72K
+5.68%
Oct 10, 2025
Deerfield Management Company, L.P.
4.89M
6.11%
--
--
Sep 30, 2025
BC Global Opportunities IX LP
4.37M
5.46%
+3.27M
+296.89%
Sep 04, 2025
Omega Fund Management, LLC
3.29M
4.11%
+3.29M
--
Sep 30, 2025
Wellington Management Company, LLP
2.96M
3.7%
+2.78M
+1504.24%
Sep 30, 2025
Alphabet, Inc.
2.82M
3.53%
+2.82M
--
Sep 30, 2025
EcoR1 Capital, LLC
2.82M
3.53%
+2.82M
--
Sep 30, 2025
Enavate Sciences GP, LLC
2.63M
3.28%
+2.63M
--
Sep 30, 2025
Citadel Advisors LLC
2.54M
3.17%
+1.11M
+77.84%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Tema Oncology ETF
0.26%
Schwab U.S. Small-Cap ETF
0.01%
iShares Health Innovation Active ETF
0%
Schwab U.S. Broad Market ETF
0%
Tema Oncology ETF
Proportion0.26%
Schwab U.S. Small-Cap ETF
Proportion0.01%
iShares Health Innovation Active ETF
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI